Company intelligence / Profile preview

Aortyx

Barcelona, Catalonia, Spainaortyx.com ↗

Ownership: Private
Employees: ~20
Development stage: Preclinical

Overview

The company has completed all prototypes of its biomimetic aortic patch. The design has been validated by over 30 key opinion leaders in vascular surgery, including most of the top global experts. Manufacturing scale-up and regulatory steps are ongoing to enable first-in-human trials within one year after their latest funding round. Market research indicates significant potential beyond initial indications.

Therapeutic areas: Cardiovascular
Modalities: Biomimetic bioresorbable endovascular patches (biomaterials/medical device)
Industry: Implantable Medical Devices

Partnerships

Collaborations with Universitat Ramon Llull IQS School of Engineering and Hospital Clínic Barcelona for R&D and clinical validation

Beyond the preview

Go deeper on Aortyx.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Aortyx.

Explore the full profile